News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
714,513 Results
Type
Article (40992)
Company Profile (300)
Press Release (673220)
Multimedia
Podcasts (87)
Webinars (14)
Section
Business (207206)
Career Advice (2077)
Deals (35913)
Drug Delivery (100)
Drug Development (82491)
Employer Resources (176)
FDA (16327)
Job Trends (15202)
News (350448)
Policy (32941)
Tag
Academia (2576)
Accelerated approval (9)
Adcomms (22)
Allergies (96)
Alliances (50372)
ALS (110)
Alzheimer's disease (1466)
Antibody-drug conjugate (ADC) (160)
Approvals (16319)
Artificial intelligence (316)
Autoimmune disease (29)
Automation (18)
Bankruptcy (364)
Best Places to Work (11757)
BIOSECURE Act (21)
Biosimilars (124)
Biotechnology (212)
Bladder cancer (94)
Brain cancer (36)
Breast cancer (368)
Cancer (2884)
Cardiovascular disease (218)
Career advice (1735)
Career pathing (33)
CAR-T (186)
CDC (33)
Cell therapy (504)
Cervical cancer (22)
Clinical research (67910)
Collaboration (1031)
Company closure (3)
Compensation (694)
Complete response letters (24)
COVID-19 (2649)
CRISPR (56)
C-suite (332)
Cystic fibrosis (113)
Data (3015)
Decentralized trials (2)
Denatured (28)
Depression (65)
Diabetes (347)
Diagnostics (6444)
Digital health (23)
Diversity (10)
Diversity, equity & inclusion (46)
Drug discovery (138)
Drug pricing (127)
Drug shortages (28)
Duchenne muscular dystrophy (126)
Earnings (88489)
Editorial (46)
Employer branding (23)
Employer resources (152)
Events (116207)
Executive appointments (864)
FDA (17983)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (934)
Gene editing (131)
Generative AI (23)
Gene therapy (380)
GLP-1 (812)
Government (4551)
Grass and pollen (5)
Guidances (181)
Healthcare (18925)
HIV (40)
Huntington's disease (30)
IgA nephropathy (39)
Immunology and inflammation (147)
Immuno-oncology (9)
Indications (40)
Infectious disease (2821)
Inflammatory bowel disease (150)
Inflation Reduction Act (11)
Influenza (62)
Intellectual property (120)
Interviews (329)
IPO (16829)
IRA (45)
Job creations (3844)
Job search strategy (1471)
Kidney cancer (13)
Labor market (52)
Layoffs (510)
Leadership (24)
Legal (7979)
Liver cancer (79)
Longevity (12)
Lung cancer (401)
Lymphoma (209)
Machine learning (11)
Management (58)
Manufacturing (390)
MASH (95)
Medical device (13479)
Medtech (13484)
Mergers & acquisitions (19806)
Metabolic disorders (866)
Multiple sclerosis (99)
NASH (16)
Neurodegenerative disease (116)
Neuropsychiatric disorders (35)
Neuroscience (2155)
NextGen: Class of 2025 (6576)
Non-profit (4507)
Now hiring (48)
Obesity (438)
Opinion (237)
Ovarian cancer (102)
Pain (107)
Pancreatic cancer (120)
Parkinson's disease (188)
Partnered (22)
Patents (298)
Patient recruitment (165)
Peanut (50)
People (58560)
Pharmaceutical (76)
Pharmacy benefit managers (22)
Phase I (21197)
Phase II (29970)
Phase III (22190)
Pipeline (1638)
Policy (212)
Postmarket research (2573)
Preclinical (9022)
Press Release (64)
Prostate cancer (141)
Psychedelics (37)
Radiopharmaceuticals (263)
Rare diseases (462)
Real estate (6041)
Recruiting (68)
Regulatory (22894)
Reports (50)
Research institute (2349)
Resumes & cover letters (355)
Rett syndrome (9)
RNA editing (8)
RSV (49)
Schizophrenia (88)
Series A (157)
Series B (108)
Service/supplier (11)
Sickle cell disease (60)
Special edition (20)
Spinal muscular atrophy (148)
Sponsored (34)
Startups (3670)
State (2)
Stomach cancer (14)
Supply chain (78)
Tariffs (61)
The Weekly (57)
Vaccines (796)
Venture capital (55)
Weight loss (265)
Women's health (50)
Worklife (20)
Date
Today (75)
Last 7 days (383)
Last 30 days (1903)
Last 365 days (31571)
2025 (16944)
2024 (35732)
2023 (40661)
2022 (51785)
2021 (56339)
2020 (54535)
2019 (46980)
2018 (35386)
2017 (32636)
2016 (32060)
2015 (38110)
2014 (32005)
2013 (26893)
2012 (29013)
2011 (29668)
2010 (27706)
Location
Africa (743)
Alabama (66)
Alaska (7)
Arizona (245)
Arkansas (14)
Asia (39521)
Australia (6372)
California (7475)
Canada (2368)
China (696)
Colorado (324)
Connecticut (322)
Delaware (194)
Europe (85386)
Florida (1129)
Georgia (247)
Hawaii (1)
Idaho (59)
Illinois (640)
India (26)
Indiana (364)
Iowa (16)
Japan (228)
Kansas (108)
Kentucky (29)
Louisiana (14)
Maine (64)
Maryland (1036)
Massachusetts (5594)
Michigan (246)
Minnesota (453)
Mississippi (3)
Missouri (90)
Montana (28)
Nebraska (25)
Nevada (80)
New Hampshire (66)
New Jersey (2091)
New Mexico (29)
New York (2100)
North Carolina (1136)
North Dakota (8)
Northern California (3284)
Ohio (236)
Oklahoma (16)
Oregon (35)
Pennsylvania (1615)
Puerto Rico (18)
Rhode Island (36)
South America (1123)
South Carolina (34)
South Dakota (1)
Southern California (2795)
Tennessee (126)
Texas (1133)
United States (27825)
Utah (220)
Virginia (188)
Washington D.C. (73)
Washington State (642)
West Virginia (4)
Wisconsin (66)
714,513 Results for "sutro biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sutro Biopharma Appoints Greg Chow as Chief Financial Officer
June 2, 2025
·
5 min read
Press Releases
Sutro Biopharma to Participate in Upcoming May 2025 Investor Conferences
May 2, 2025
·
1 min read
Press Releases
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights
May 8, 2025
·
12 min read
Press Releases
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
April 28, 2025
·
5 min read
Layoffs
Sutro Cuts Half of Staff, Deprioritizes ADC in Strategic Review
Sutro’s stock tumbled nearly 19% after the company announced it will sideline its FRα-targeted antibody-drug conjugate luveltamab tazevibulin, which it was studying for ovarian cancer. The biotech will seek licensing opportunities for the asset.
March 14, 2025
·
3 min read
·
Tristan Manalac
Business
VGXI Inc. announces a strategic partnership with Sutro Biopharma Inc. to support growing clinical pipeline
VGXI, Inc. has entered into a strategic partnership with Sutro Biopharma, Inc. to support clinical production of luveltamab tazevibulin, abbreviated as “luvelta”, a novel Folate Receptor-α -targeting antibody-drug conjugate with the potential to address the unmet need in several FRα-expressing cancers.
June 3, 2024
·
4 min read
Press Releases
Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights
March 14, 2025
·
7 min read
Press Releases
Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference
March 4, 2025
·
1 min read
Press Releases
Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline
March 14, 2025
·
8 min read
Business
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones
Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today reported its financial results for the first quarter of 2024, its recent business highlights, and a preview of select anticipated milestones.
May 13, 2024
·
10 min read
1 of 71,452
Next
